Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ · Healthcare
Verrica Pharmaceuticals Inc. Income Statement 2021–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | 35.6M | 7.6M | 5.1M | 9.0M | 12.0M |
| Gross Profit | — | — | — | — | — |
| Profitability | |||||
| Operating Income | -12.2M | -65.9M | -65.8M | -21.3M | -30.9M |
| EBITDA | — | — | — | — | — |
| Net Income | -17.9M | -76.6M | -67.0M | -24.5M | -35.1M |
| Per Share Data | |||||
| EPS (diluted) | — | — | — | — | — |
| Shares Outstanding (dil.) | 11M | 5M | 45M | 34M | 27M |
Verrica Pharmaceuticals Inc. Income Statement — FAQ
Verrica Pharmaceuticals Inc. (VRCA) income statement over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VRCA's income statement history?
The chart and table above show Verrica Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.